Cosette Pharmaceuticals completed the acquisition of Endoceutics.

Cosette Pharmaceuticals, a US-based, diversified pharmaceutical company with a proven topicals and dermatology portfolio and a growing branded pharmaceuticals business, completed the acquisition of Endoceutics, a pharmaceutical company. Financial terms were not disclosed. “I firmly believe in this product. It's a competitive market, but the drug is growing in several countries. We managed to have an exclusive long-term renewable contract. We will be able to capitalize on the assets and the team, which has great expertise,” Zaâfar Zerhouni, MSH Pharma CEO.